Campbell Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MCM
CFA
RJA
CAN
Campbell Wealth Management's ARKG Position: Q3 2020 in Review
Campbell Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2020, closing a stake of 388 shares — an estimated $20K sold.
Campbell Wealth Management first reported a position in ARKG in Q2 2020 and held it in 1 quarter. The position peaked at $20K in Q2 2020. 243 funds tracked by Wall St. Rank hold ARKG as of Q3 2020.
- Campbell Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2020 after selling out during the quarter.
- Campbell Wealth Management sold 388 ARK Genomic Revolution ETF shares in Q3 2020, an estimated $20K.
- Campbell Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 1 quarter.
- Campbell Wealth Management's ARK Genomic Revolution ETF position peaked at $20K in Q2 2020.
- 243 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2020.
Based on Campbell Wealth Management's 13F filing for Q3 2020, filed 2 Nov 2020.